Navigation Links
FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
Date:2/26/2009

ferent types of insulins (rapid-acting vs. long-acting). The differentiation of the Apidra(R) SoloSTAR(R) and Lantus(R) SoloSTAR(R) was shown in a specific comparative study. Nevertheless, before using Apidra(R) SoloSTAR(R) or Lantus(R) SoloSTAR(R), patients should carefully examine the labeling on the pen, to ensure they are using the correct one. Apidra(R) SoloSTAR(R) operates with a low injection force and two studies found that this delivery device required less injection force than the Novo Nordisk FlexPen and the Eli Lilly Humulin/Humalog pen.

Apidra(R) SoloSTAR(R) is expected to be available in pharmacies this year.

For more information on Apidra(R) or Apidra(R) SoloSTAR(R) please visit www.Apidra.com.

For more information on Lantus(R) or Lantus(R) SoloSTAR(R) please visit www.Lantus.com.

About Diabetes

Diabetes is a chronic, widespread condition in which the body does not produce or properly use insulin, the hormone needed to transport glucose (sugar) from the blood into the cells of the body for energy. More than 230 million people worldwide are living with the disease and this number is expected to rise to a staggering 350 million within 20 years. It is estimated that nearly 24 million Americans have diabetes, including an estimated 5.7 million who remain undiagnosed. At the same time, approximately 40 percent of those diagnosed are not achieving the blood sugar control target of A1C <7 percent recommended by the ADA. The A1C test measures average blood glucose levels over the past two- to three-month period.

About Apidra(R) and Apidra(R) SoloSTAR(R)

Apidra(R) w
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
3. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
4. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
7. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
8. FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
9. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
10. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
11. FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Calif. , Feb. 26, 2015   Regulus ... biopharmaceutical company leading the discovery and development of innovative ... Xanthopoulos , Ph.D., President and Chief Executive Officer of ... and Company 35 th Annual Healthcare Conference on ... conference is being held at the Boston Marriott Copley ...
(Date:2/26/2015)... 26, 2015  NuGene International, Inc. ("NuGene") (OTCQB: ... skin and hair rejuvenation, has announced that it ... record for investor relations and strategic communications. ... sales and diversification strategies – and we need ... shareholders," stated Ali Kharazmi CEO of NuGene when ...
(Date:2/26/2015)... 26, 2015 Innovation is more ... from unexpected parts of the world and transforming ... agriculture to manufacturing to health care, disruption is ... realities and socio-political trends shake the foundations of ... ingredient for CEOs to survive the next wave ...
(Date:2/26/2015)... , Feb. 26, 2015 Ceres, ... Partner status in Oracle PartnerNetwork. In attaining Gold Level ... commitment to establish Oracle-related knowledge in delivering Ceres, Persephone ... of joint customers. Originally developed for in-house ... rapidly zoom in and out of massive amounts of ...
Breaking Biology Technology:Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Ceres Becomes Oracle PartnerNetwork Gold Level Partner 2Ceres Becomes Oracle PartnerNetwork Gold Level Partner 3Ceres Becomes Oracle PartnerNetwork Gold Level Partner 4
... New ultra-clean nanowires produced at the Nano-Science Center, University ... development of new high-efficiency solar cells and electronics on ... Institute, in collaboration with a number of well-known researchers ... The new findings have recently been published in the ...
... ... ... var shortURL ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for ...
... Shareholder -- ANTONY, France, November 10, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
Cached Biology Technology:New ultra-clean nanowires have great potential 2Atrium Innovations Announces Third Quarter Financial Results of 2010 2Atrium Innovations Announces Third Quarter Financial Results of 2010 3Atrium Innovations Announces Third Quarter Financial Results of 2010 4Atrium Innovations Announces Third Quarter Financial Results of 2010 5Atrium Innovations Announces Third Quarter Financial Results of 2010 6Atrium Innovations Announces Third Quarter Financial Results of 2010 7Atrium Innovations Announces Third Quarter Financial Results of 2010 8Atrium Innovations Announces Third Quarter Financial Results of 2010 9Atrium Innovations Announces Third Quarter Financial Results of 2010 10Atrium Innovations Announces Third Quarter Financial Results of 2010 11Atrium Innovations Announces Third Quarter Financial Results of 2010 12Atrium Innovations Announces Third Quarter Financial Results of 2010 13Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder 2Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder 3Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder 4Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder 5Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder 6Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder 7Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder 8
(Date:2/23/2015)... , Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62114357 for DISTRIBUTED VOICE DIRECTED ... NXT-ID introduces a new groundbreaking payment method. Payment accounts ... account may only be accessed if both the speech ...
(Date:2/12/2015)... OXFORD, Conn. , Feb. 12, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62/113114 for ... MULTIPLE DEVICES. The patent further establishes NXT-ID,s ... to its intellectual property portfolio the ability for multiple ...
(Date:2/5/2015)... RESEARCH TRIANGLE PARK, N.C. , Feb. 5, 2015 ... as a specialist logistics company and has launched a ... industry,s only Clinical Logistics Organization (CLO).  The new campaign ... with emphasis on patient, protocol and shipments. ... Patient First , aligns Marken,s priorities with its ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken Launches New Patient-Centric Campaign 2
... from nature. After years of wondering how organisms managed ... discovered the simple secret. , Scientists already knew that ... out of stubborn chemical concoctions to generate a large ... The question was, how do they do it? , ...
... agency that oversees childhood vaccinations today recommended a ... a common childhood illness that is the single ... children worldwide. Three scientists associated with The Children's ... co-inventors of the vaccine, based on research dating ...
... A small Pacific Islands nation has distinguished itself on ... it is creating the third largest marine protected area ... the planet's most pristine coral reefs. , Martin Puta ... the Republic of Kiribati, announced the establishment of the ...
Cached Biology News:MIT chemist discovers secret behind nature's medicines 2New Rotavirus vaccine joins routine infant immunization schedule 2Pacific Islands paradise protected 2Pacific Islands paradise protected 3